TAM
TBPH icon

Tocqueville Asset Management’s Theravance Biopharma TBPH Stock Holding History

Tocqueville Asset Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27,500
Closed -$561K – 753
2021
Q1 		$561K Buy
27,500
+16,700
+155% +$317K 0.01% 526
2020
Q4 		$192K Buy
+10,800
New +$194K ﹤0.01% 685
2014
Q3 		– Sell
-5,714
Closed -$182K – 1239
2014
Q2 		$182K Buy
+5,714
New +$172K ﹤0.01% 986

Other funds holding TBPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Tocqueville Asset Management's TBPH Position: Q2 2021 in Review

Tocqueville Asset Management sold out of Theravance Biopharma (TBPH) in Q2 2021, closing a stake of 27,500 shares — an estimated $561K sold.

Tocqueville Asset Management first reported a position in TBPH in Q2 2014 and held it in 3 quarters. The position peaked at $561K in Q1 2021. 108 funds tracked by Wall St. Rank hold TBPH as of Q2 2021.

  • Tocqueville Asset Management reported no remaining Theravance Biopharma position as of Q2 2021 after selling out during the quarter.
  • Tocqueville Asset Management sold 27,500 Theravance Biopharma shares in Q2 2021, an estimated $561K.
  • Tocqueville Asset Management first reported a position in Theravance Biopharma in Q2 2014 and held it in 3 quarters.
  • Tocqueville Asset Management's Theravance Biopharma position peaked at $561K in Q1 2021.
  • 108 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2021.

Based on Tocqueville Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.